Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michałowska-Wender

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Folia Neuropathologica|March 8, 2000
The early stage of multiple sclerosis in the light of molecular and immunological studiesG Michałowska-Wender
Acta Neurologica Scandinavica|June 18, 2002
In vivo effect of interferon-beta 1a on interleukin-12 and TGF-beta(1) cytokines in patients with relapsing-remitting multiple sclerosisJ Losy, G Michałowska-Wender
Neurologia I Neurochirurgia Polska|July 24, 2001
[Surface CD2, CD4, CD8 markers and IL-2 and TNF-alpha cytokines in amyotrophic lateral sclerosis]J Losy, G Michałowska-Wender
Folia Neuropathologica|October 27, 2001
Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patientsG Michałowska-Wender, J Losy, M Wender
Neurologia I Neurochirurgia Polska|January 1, 1995
[Limited value of colloidal tests in CSF in the diagnosis of multiple sclerosis]G Michałowska-Wender, J Losy, M Wender
Acta Neurologica Scandinavica|January 1, 1994
The effect of large-dose prednisone therapy on IgG subclasses in multiple sclerosisJ Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|January 1, 1996
IgG subclasses in neurological disordersJ Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|May 1, 1992
[IgG1-IgG4 subclasses in the cerebrospinal fluid and blood serum and their synthesis in the central nervous system in multiple sclerosis]J Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|November 1, 1993
[Determination of IgG subclass antibodies to the basic myelin protein in patients with multiple sclerosis]J Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|January 11, 2002
[Chemokines MIP-1 and MCP-1 and patients with multiple sclerosis treated with interferon beta-1a]J Losy, G Michałowska-Wender, M Wender
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Folia Neuropathologica|March 8, 2000
The early stage of multiple sclerosis in the light of molecular and immunological studiesG Michałowska-Wender
Acta Neurologica Scandinavica|June 18, 2002
In vivo effect of interferon-beta 1a on interleukin-12 and TGF-beta(1) cytokines in patients with relapsing-remitting multiple sclerosisJ Losy, G Michałowska-Wender
Neurologia I Neurochirurgia Polska|July 24, 2001
[Surface CD2, CD4, CD8 markers and IL-2 and TNF-alpha cytokines in amyotrophic lateral sclerosis]J Losy, G Michałowska-Wender
Folia Neuropathologica|October 27, 2001
Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patientsG Michałowska-Wender, J Losy, M Wender
Neurologia I Neurochirurgia Polska|January 1, 1995
[Limited value of colloidal tests in CSF in the diagnosis of multiple sclerosis]G Michałowska-Wender, J Losy, M Wender
Acta Neurologica Scandinavica|January 1, 1994
The effect of large-dose prednisone therapy on IgG subclasses in multiple sclerosisJ Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|January 1, 1996
IgG subclasses in neurological disordersJ Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|May 1, 1992
[IgG1-IgG4 subclasses in the cerebrospinal fluid and blood serum and their synthesis in the central nervous system in multiple sclerosis]J Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|November 1, 1993
[Determination of IgG subclass antibodies to the basic myelin protein in patients with multiple sclerosis]J Losy, G Michałowska-Wender, M Wender
Neurologia I Neurochirurgia Polska|January 11, 2002
[Chemokines MIP-1 and MCP-1 and patients with multiple sclerosis treated with interferon beta-1a]J Losy, G Michałowska-Wender, M Wender
Pageof 3